Autologous epidermal transplantation for human burn management is an example of a significant breakthrough in tissue engineering. However, the main drawback with this treatment remains the fragility of these grafts during and after surgery. A new human bilayered skin equivalent (hSE) was produced in our laboratory to overcome this problem. The aim of the present work was to study skin regeneration after hSE grafting onto nude mice. A comparative study was carried out over a period of 90 days, between anchored bovine skin equivalent, hSE and hSE+, the latter containing additional matrix components included at concentrations similar to those in human skin in vivo. The addition of a dermal layer to the epidermal sheet led to successful graft take, enhanced healing, and provided mechanical resistance to the grafts after transplantation. In situ analysis of the grafts showed good ultrastructural organization, including the deposition of a continuous basement membrane 1 week after surgery.
Preparation of anchored SE. Human keratinocytes were isolated using thermolysin before trypsin digestion of the epidermis, and cultured as described previously (30) . Human dermal fibroblasts were isolated by collagenase digestion and then cultured (21) .
The anchorage method of dermal equivalents (DE) that avoids collagen gel contraction, described previously (14) , was adapted to facilitate SE manipulations.
Briefly, a 5-mm-wide ring of unglued paper filter (Whatman, Maidstone, UK) was used as peripheral anchorage (31) . All SE were prepared in 81-cm 2 bacteriological dishes (already containing the anchorage) (32) .
Bovine type I collagen DE production has already been described (32) , and is based on the initial method described by Bell et al. (11) . DE were covered with 20 ml of Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 IU/ml penicillin G, and 25 µg/ml gentamicin following collagen polymerization. The final concentrations of bovine type I collagen and fibroblast in DE were 2 mg/ml and 12,500 cells/ml, respectively.
For human collagen DE production, a stock solution of human type I and III collagen (63:37) (Imedex, Chaponost, France) was prepared by dissolving 6.26 mg/ml of the mixture in apyrogen water. A solution of 9.3 ml of Dulbecco's modified Eagle's medium 2.7 × (containing 40% fetal calf serum, 200 IU/ml penicillin G, and 25 µg/ml of gentamicin), 8 ml of the stock collagen solution, and 1 ml of elastin (1.336 mg/ml in 0.2 M Tris [pH 8.0]) was mixed with 1 ml of a second solution containing 0.062 mg of hyaluronic acid, 0.122 mg of chondroitin sulfate, 0.002 mg of heparan sulfate (Sigma) dissolved in apyrogen water, 0.016 ml of 4 N HCl, and 1 ml of a dermal fibroblast suspension (2.5 × 10 5 cells/ml). This mixture was quickly distributed in bacteriological petri dishes to obtain human DE containing additional dermal matrix components. Another formulation that did not contain elastin and the second solution (replaced by 1 ml of Tris 0.2 M and 1 ml of apyrogen water) was also prepared to produce human DE. The final concentrations of human type I and III collagens and fibroblasts in these DE were 2.9 mg/ml and 12,500 cells/ml, respectively.
Keratinocytes were plated on 4-day-old bovine DE, human DE, and human DE containing additional dermal matrix components at a concentration of 9 × 10 5 cells/cm 2 . SE were cultured in Dulbecco-Vogt modification of Eagle medium with Ham's F12 containing serum and additives (32) . The three types of skin substitutes (bovine skin equivalent [bSE] , human skin equivalent [hSE] , and human skin equivalent containing additional dermal matrix components [hSE+]) were grafted onto nude mice after being cultured for 15 to 18 days. Before grafting, the anchorage was removed and SE were mounted on a Vaseline gauze to facilitate manipulation.
Animals and surgical manipulations. An animal model was established in our laboratory (33) , and subsequently was further improved (7) . Briefly, athymic nu/nu CD-1 male adult mice (Charles River Laboratories, Lasalle, QC, Canada) were anesthetized with a solution of ketamine-xylasine. A 2-cm incision was made through the dorsal skin. The loose connective tissue under the panniculus carnosus was excised. A silicone Fusenig's chamber (5,34) (made in our laboratory) was implanted ( Fig. 1 ) and the SE, covered by a sterile gauze, was deposited directly on the dorsal muscle of the mouse. The gauze was removed on day 7 after grafting to allow epidermal keratinization. The graft take was assessed clinically on days 7, 14, and 21, and the standardized pictures produced were read with planimetric scales to obtain the percentage of take and contraction of each equivalent. One to four mice per group of SE tested were killed on the 4th, 14th, 21th, 28th, and 90th day after grafting for graft analysis. Each experiment was performed twice and gave similar results. Twenty-seven mice received grafts.
Histological and ultrastructural analyses. The grafts were excised, fixed in Bouin's solution, and embedded in paraffin. Four-micrometer-thick tissue sections were processed for standard hematoxylin, phloxine, and saffron staining. Some biopsies were also processed and mounted for electron microscope analyses, as described previously (7).
Indirect immunofluorescence staining. Rabbit polyclonal anti-type IV collagen and mouse monoclonal anti-HLA-A,B,C antibodies were kindly provided by Dr. Pascal Summer (Pasteur Institute, Lyon, France) and Dr. Raynald Roy (Laval University, Quebec, Canada), respectively. Rat monoclonal antilaminin antibody was bought from AMAC (BIO/CAN Scientific Inc., Mississauga, Ontario, Canada). Mouse monoclonal antiepithelial keratins AE3 and AE2 antibodies were purchased from ICN Immunobiologicals (Lisle, IL). Mouse monoclonal anti-human type I collagen antibody was bought from Biodesign (Kennebunk, ME). Mouse anti-human keratinocyte transglutaminase antibody was purchased from BTI (Stoughton, MA). Mouse monoclonal anti-human type VII collagen, FITC-conjugated goat anti-mouse IgG-IgM, sheep anti-rabbit IgG, and goat anti-rat IgG antibodies were purchased from Chemicon (Ingram-Bell, Montreal, Canada). Bullous pemphigoid human antigen anti-serum was kindly supplied by Dr. Ernest Heid's laboratory (Service de Dermatologie, Hôpital Civil de Strasbourg, France). FITC-conjugated protein A was purchased from Sigma. The histological immunostaining was performed on frozen tissue sections fixed with acetone.
Inflammatory response of C3H/HeN mice to bovine or human collagens.
A volume of 100 µl of 2 mg/ml bovine type I (Sigma) or 2.9 mg/ml human types I and III collagen suspension was injected subcutaneously under sterile conditions into two independent groups of immunocompetent C3H/HeN mice. A control group was given injections with the same volume of glacial acetic acid diluted 1000 times with apyrogenic water. Mice skin biopsies were performed 14 days after injection in order to proceed with histological analysis.
RESULTS
In situ postgrafting analysis. The graft take was evaluated for each SE, as a percentage of the grafted surface. It was already possible to observe a good adhesion of all types of SE to the graft bed as soon as 7 days after their transplantation (hSE+ and bSE: Fig. 1 , A and B, respectively; hSE: not shown). At this time, 99±1% graft take was observed with bSE (n=8) and hSE+ (n=5) after grafting. The hSE transplantation already led to 100±0% (n=4) graft take after the same period after surgery. From day 14 after grafting to the end of the experiment, 100% graft take was obtained for all types of transplanted SE. The development of a well-organized stratum corneum that progressively thickened in situ was seen in all cases. No sign of tissue necrosis was ever observed.
The contraction of all SE was also monitored at 7, 14, 21, and 28 days after grafting. Indeed, SE contraction was observed, increasing with time after grafting (Table 1) . However, hSE and hSE+ showed lower contraction than bSE throughout the whole period evaluated after grafting (Table 1) . On the 28th day after SE transplantation, 61±5% of the initial hSE surface area remained, compared with 48±4% for bSE ( Table 1) . Table 1 . Percentage of surface area after contraction of SE grafted on nude mice a Histological analysis: Human epidermal production and grafting. Some SE from each tested group were analyzed to verify the histological integrity of the cultured tissues prior to transplantation (hSE+ and bSE: Fig. 2 , A and B, respectively; hSE: not shown). As soon as 4 days after grafting, hSE epidermis was composed of 10-15 cell layers, including spinous and granular regions (Fig. 2C) . In both hSE and hSE+, the basal cells had retained their cuboidal morphology and the formation of a stratum corneum was in progress. Similar observations were made on bSE (Fig. 2D) . The human epidermis of all SE types progressively increased in thickness, leading to the establishment of stratified epidermal layers from 21 up to 90 days after grafting (hSE+: Fig. 3 , A and B; bSE and hSE: not shown). Interestingly, the number of fibroblasts had decreased in the dermal layer of all types of SE (bSE, hSE, and hSE+) after 90 days (hSE+: Fig. 3B ; bSE and hSE: not shown), compared with 21 days after grafting (hSE+: Fig. 3A ; bSE and hSE: not shown). Basement membrane development in situ. The deposition of various basement membrane constituents was evaluated by immunofluorescence tissue labeling over time after grafting. As soon as 4 days after all SE transplantation, a positive and continuous basement membrane labeling was observed with antilaminin (hSE+: Fig. 5A ; bSE: Fig. 5B ; hSE: not shown), anti-type IV collagen (hSE+: Fig. 5C ; bSE: Fig. 5D ; hSE: not shown), and bullous pemphigoid antigen antibodies (hSE+: Fig. 5E ; bSE: Fig. 5F ; hSE: not shown). Bullous pemphigoid antigens were also detected in the cytoplasm of the basal cells, 4 days after transplantation. The results obtained from hSE analyses were similar to the data observed with the two other groups of SE evaluated.
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Transglutaminase detection. The detection of transglutaminase in the epidermal cell layers of the SE was evaluated by immunofluorescence staining of tissue sections. As shown in Figure 6E (hSE+), positive transglutaminase labeling was observed in the last suprabasal and the first stratum corneum epidermal cell layers, 90 days after grafting. Similar observations were done on bSE and hSE histological sections (data not shown). These results strongly suggest that the enzymatic cross-linking of the SE stratum corneum by transglutaminase is still going on in the human keratinocytes in situ.
SE epidermal cell differentiation and stratification. As expected from the histological observations, keratin labeling revealed that the human keratinocytes seeded on all SE groups can differentiate and adopt a stratified structural organization, for all time periods examined. The antikeratin antibody AE3 (hSE+: Fig.  6F ) similarly labeled the whole epidermis of all SE groups (bSE and hSE: data not shown). The antikeratin antibody AE2, which reacts more specifically with keratins of the suprabasal epidermal layers, did not stain the basal epidermal cells of the grafts (hSE+: Fig. 6G ). These observations are consistent with the differential pattern of keratin expression in keratinocytes in vivo.
Human type I collagen detection in the graft dermis. Human type I collagen was detected equally in all hSE and hSE+ dermal compartments, 21 days after grafting (data not shown). A similar immunolabeling signal was observed in the dermis of all bSE. At this point, it is important to mention that the anti-human type I collagen antibody cross-reacts with bovine type I collagen, but not with murine type I collagen.
Human type I collagen could still be detected in both hSE (not shown) and hSE+ (Fig. 6H ) on day 90 after transplantation. However, human/bovine type I collagen staining led to a sparse distribution of weaker signals in all bSE histological sections grafted for the same time period.
Ultrastructural analyses of all SE revealed that some hemidesmosomes, lamina densa, and lamina lucida were present early after transplantation (hSE+: Fig.  7A ; bSE and hSE: not shown), and all groups of grafts showed very good ultrastructural organization thereafter (hSE+: Fig. 7B ; bSE and hSE: not shown). 
Inflammatory response of C3H/HeN mice to bovine or human collagens.
Polymorphonuclear leukocyte infiltration occurred at the site of the subcutaneous injection of bovine type I collagen after 14 days in immunocompetent mice (Fig. 8A) . A slight inflammatory reaction was seen in response to the human collagen injection (Fig. 8B ), but was never comparable to the immune cell migration observed with bovine collagen (Fig. 8A ). Histological analysis of the injection sites did not reveal any inflammatory reaction in the control mice (data not shown). 
DISCUSSION
The production of bioengineered human tissues has led to a fascinating diversity of medical applications, notably for permanent burn wound coverage (35) . During the last 5 years, various skin substitutes have been introduced for extensive third-degree burn management, providing new approaches in reconstructive surgery (15) (16) (17) (18) (19) (20) (21) (22) . A choice between two therapeutic options or their combination may soon be possible: (1) temporary coverage of the burn sites with cadaver or animal skin (36,37), before autografting, or (2) permanent transplantation of various types of bioengineered SE (15) (16) (17) (18) (19) (20) (21) (22) . The second option may present practical and esthetic advantages but could entail some risks of microbial infections or long-term immunoreactions to the allogeneic components present in most of the bioengineered tissue grafts (28, 29, 38) .
Collagens are frequently chemically modified or lyophilized so they can be used as specialized dressings, notably in skin substitutes (16) (17) (18) 39) . These modifications often slow down its degradation after grafting in vivo (40) . However, collagenic dermal substitutes should retain their permeability to allow the diffusion of nutriments or growth factors (39) and vascularization in vivo (41) . Our living SE presents such advantages and can be produced with human collagens and autologous cells, which minimize the risks of inflammatory or immunological reactions in vivo. Moreover, the human living dermal and epidermal cells contribute to (1) initiate structural organization of the SE in culture (31) and (2) enhance permanent graft remodeling after transplantation (42) . In our hSE+, we used bovine elastin, porcine chondroitin sulfate B, and bovine heparan sulfate in order to determine whether they improved graft take. These components will be introduced only in eventual patient autologous SE grafts when commercially available from a human source.
The contraction of cell-populated collagen lattice over time in culture has been well documented (11, (42) (43) (44) . The contractile properties of fibroblasts lead to severe reduction of the initial surface of floating DE (11) . Until now, the use of SE has been limited because of the contraction associated with maturation of the dermal component in vitro (19, 45) . However, this drawback was obviated in culture by the peripheral anchorage method, established in our laboratory (14, 31) . Our data showed that all types of living SE led to 100% graft take, even over the backbones of mice, a site particularly difficult to engraft in this animal model. The histological analyses of all SE groups (bSE, hSE, and hSE+) showed well-stratified human epidermal cell layers for the whole period studied (90 days) in situ after grafting. Moreover, immunofluorescence and ultrastructural studies of the grafts allowed the detection of a continuous basement membrane, containing several human components, such as laminin, bullous pemphigoid antigens, and types IV and VII collagen. In addition, human keratins and transglutaminase were also observed and expressed as expected, in respective epidermal cell layers on immunohistological SE sections, 90 days after transplantation. These results strongly suggest that the human epidermal cells, seeded in all groups of SE grafted, undergo a normal pattern of differentiation in situ and seem to retain functional activities for long periods of time after transplantation.
Immunohistological detection of human type I collagen in the dermal section of the hSE and hSE+ grafted for 90 days leads to two hypotheses. Either this human collagen was secreted by the human SE, or it was not completely degraded in situ after grafting. In the case of mice grafted with bSE, we could not determine whether the type I collagen detected was of human or bovine origin. Thus, the same two hypotheses still apply. However, on day 90 after transplantation, considerably less type I human (or bovine) collagen was observed on bSE dermal sections, compared with hSE and hSE+. This observation correlates with data obtained from in vitro studies which showed a higher amount of a 92-kDa gelatinase secreted in the culture supernatants of bSE, compared with hSE and hSE+ (32) . Perhaps such an enzyme is also secreted by the human SE cells after grafting, and it may contribute to accelerating the degradation of the bSE dermal collagen matrix. Nevertheless, such results are very promising for the eventual use of living SE as autologous human wound coverage. Indeed, living SE contracted with time after transplantation; interestingly, however, our data suggest that the use of human collagen tends to reduce such contraction, compared with bovine collagen.
Our bilayered SE were readily transplanted in vivo in a single-step surgical procedure, under the best aseptic and physiological wound bed conditions. However, the situation may be different on extensively burned patients due to the dramatic extent of the cutaneous trauma and the size of each SE graft. We are conducting experiments to evaluate the feasibility of SE transplantation in a sequential approach. This dermal layer would first be grafted to close the wounds as soon as possible. This would be followed by the overlaying of epithelial sheets in a second step. The sequential transplantation of dermal and epithelial skin layers on nude mice will be compared with the single-step SE grafting. Covering of the wounds before epithelialization has already been applied in therapy for burned patients (23, 24, 42, 44) . The presence of living fibroblasts in the dermal substitutes strongly enhances wound healing and vascularization compared with human acellular substitutes (42) . The decreased number of fibroblasts in the dermal layer of SE 90 days after grafting suggests that a growth regulatory process may have occurred in vivo. Indeed, extracellular matrix secretion and reorganization, combined with the effects of several cytokines, may contribute to regulating growth of both fibroblasts and keratinocytes in situ.
The results of the present work show better graft take and histological evolution of anchored SE compared with cultured epidermal sheets transplanted on an animal model. Our data indicate that hSE can be used as a valuable therapeutic option for human burn management. This skin model can also be used for several biotechnological research applications. These new anchored SE have an adequate surface for clinical grafting and are readily amenable to large-scale production for autologous burn wound coverage by tissue-engineering methods. Table 1 Figure 2 Ovid: GRAFTING ON NUDE MICE OF LIVING SKIN EQU... http://ovidsp.tx.ovid.com.acces.bibl.ulaval.ca/sp-3.18.0b/ovidw... 
